Thomas Smith
Stock Analyst at Leerink Partners
(4.99)
# 40
Out of 4,534 analysts
681
Total ratings
55.9%
Success rate
51.4%
Average return
Main Sectors:
Stocks Rated by Thomas Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Initiated Coverage: Buy | $38 | $18.21 | +108.68% | 1 | Jul 6, 2026 | |
| ALT Altimmune | Initiated Coverage: Buy | $10 | $2.81 | +255.87% | 1 | Jun 22, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $12.22 | - | 8 | Jun 12, 2026 | |
| XFOR X4 Pharmaceuticals | Initiated Coverage: Buy | $12 | $3.68 | +226.09% | 1 | Jun 2, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | n/a | $74.38 | - | 27 | Jun 2, 2026 | |
| EQ Equillium | Upgraded: Buy | $6 | $2.47 | +142.91% | 34 | May 28, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | n/a | $8.18 | - | 17 | May 27, 2026 | |
| ALMS Alumis | Reiterated: Buy | $32 | $27.98 | +14.37% | 13 | May 15, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | $106 | $97.33 | +8.91% | 1 | Apr 13, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $50 | $18.56 | +169.40% | 39 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $50 | $39.92 | +25.25% | 37 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $52 | $11.53 | +351.00% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $11.98 | +200.50% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.20 | - | 20 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.42 | +171.80% | 1 | Jan 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $32 | $7.24 | +341.99% | 18 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 102.00 | kr 32.64 | +212.50% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $36.38 | +224.35% | 38 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.51 | - | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.57 | +25.67% | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $115 | $131.50 | -12.55% | 17 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $14 | $19.05 | -26.51% | 32 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $780 | $846.19 | -7.82% | 35 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.42 | - | 40 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $535.69 | - | 39 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $7.16 | +263.13% | 15 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.86 | +107.25% | 34 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $10.61 | +229.88% | 52 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.04 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $16.75 | n/a | 16 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $15.00 | n/a | 28 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $16.77 | n/a | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.98 | n/a | 25 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $1.07 | n/a | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $111.06 | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.50 | n/a | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2 | $32.99 | n/a | 16 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 5,207p | 125p | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $21 | $8.30 | n/a | 1 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $6 | $2.11 | n/a | 1 | Sep 8, 2017 |
Avalo Therapeutics
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $18.21
Upside: +108.68%
Altimmune
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.81
Upside: +255.87%
Climb Bio
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.22
Upside: -
X4 Pharmaceuticals
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.68
Upside: +226.09%
Disc Medicine
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $74.38
Upside: -
Equillium
May 28, 2026
Upgraded: Buy
Price Target: $6
Current: $2.47
Upside: +142.91%
Cartesian Therapeutics
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.18
Upside: -
Alumis
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $27.98
Upside: +14.37%
Spyre Therapeutics
Apr 13, 2026
Reiterated: Buy
Price Target: $106
Current: $97.33
Upside: +8.91%
Viridian Therapeutics
Apr 6, 2026
Reiterated: Buy
Price Target: $50
Current: $18.56
Upside: +169.40%
Apr 2, 2026
Reiterated: Buy
Price Target: $52 → $50
Current: $39.92
Upside: +25.25%
Mar 6, 2026
Reiterated: Buy
Price Target: $42 → $52
Current: $11.53
Upside: +351.00%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $11.98
Upside: +200.50%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.20
Upside: -
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.42
Upside: +171.80%
Dec 15, 2025
Reiterated: Buy
Price Target: $25 → $32
Current: $7.24
Upside: +341.99%
Nov 26, 2025
Initiated Coverage: Buy
Price Target: kr 102.00
Current: kr 32.64
Upside: +212.50%
Oct 23, 2025
Reiterated: Buy
Price Target: $118
Current: $36.38
Upside: +224.35%
Oct 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.51
Upside: -
Oct 15, 2025
Reiterated: Buy
Price Target: $7
Current: $5.57
Upside: +25.67%
Oct 8, 2025
Reiterated: Buy
Price Target: $104 → $115
Current: $131.50
Upside: -12.55%
Oct 1, 2025
Maintained: Buy
Price Target: $73 → $14
Current: $19.05
Upside: -26.51%
Sep 17, 2025
Reiterated: Buy
Price Target: $780
Current: $846.19
Upside: -7.82%
Aug 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $35.42
Upside: -
Aug 19, 2025
Maintained: Buy
Price Target: n/a
Current: $535.69
Upside: -
Aug 18, 2025
Reiterated: Buy
Price Target: $26
Current: $7.16
Upside: +263.13%
Aug 15, 2025
Reiterated: Buy
Price Target: $8
Current: $3.86
Upside: +107.25%
Aug 7, 2025
Reiterated: Buy
Price Target: $35
Current: $10.61
Upside: +229.88%
Apr 16, 2025
Maintained: Hold
Price Target: n/a
Current: $15.04
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $58
Current: $16.75
Upside: n/a
Aug 8, 2024
Maintained: Hold
Price Target: $5
Current: $15.00
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $6
Current: $16.77
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $7
Current: $3.98
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $46
Current: $1.07
Upside: n/a
Aug 7, 2024
Maintained: Hold
Price Target: $33
Current: $111.06
Upside: n/a
Mar 15, 2024
Maintained: Buy
Price Target: n/a
Current: $7.50
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: $13 → $2
Current: $32.99
Upside: n/a
Aug 8, 2022
Maintained: Buy
Price Target: 5,207p
Current: 125p
Upside: n/a
Jan 17, 2019
Initiated Coverage: Hold
Price Target: $21
Current: $8.30
Upside: n/a
Sep 8, 2017
Initiated Coverage: Hold
Price Target: $6
Current: $2.11
Upside: n/a